Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer
In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office
Cancer society, In Major Restructure, Forms New Executive Committee, Bylaws
Mass. Passes Tobacco Tax, ACS Lauds Victory Over Cigarette Industry
DCE To Provide $3.4 Mil. For Follow-Up Of DES Daughters; Board k’s Tw RFAs, Contracts
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Trump targets HHS in $810M appropriations clawback
- Two years after FDA’s breast density notification rule, there is still no standard for follow-up
So far, 38 million patients have received a dense breast notification. Now what?









